Andrew Adams
About Andrew Adams
Andrew Adams is a Co-Founder and Managing Partner at Oak HC/FT, where he has worked since 2014. He serves on the board of directors for several healthcare companies and has a strong background in investment and company growth.
Work at Oak HC/FT
Andrew Adams has served as Co-Founder and Managing Partner at Oak HC/FT since 2014. Based in Stamford, CT, he has played a significant role in shaping the firm's investment strategy and portfolio management. His focus is primarily on healthcare and financial services sectors, where he guides companies through various stages of growth. Under his leadership, Oak HC/FT has made strategic investments in several notable companies, contributing to the firm's reputation in the venture capital landscape.
Board Memberships
Andrew Adams holds board positions at multiple healthcare-focused companies, including Everside Health and WithMe Health. His involvement in these organizations reflects his commitment to advancing healthcare solutions and supporting innovative business models. As a board member, he provides strategic oversight and guidance, leveraging his extensive experience in the healthcare investment sector to drive organizational growth and success.
Education and Expertise
Andrew Adams earned a Bachelor of Arts (BA) in History from Princeton University. His academic background has equipped him with analytical skills that are beneficial in his investment career. His expertise spans various aspects of venture capital, particularly in healthcare, where he has successfully guided companies from seed funding to growth stages, demonstrating a comprehensive understanding of the industry's dynamics.
Professional Background
Before co-founding Oak HC/FT, Andrew Adams worked as a General Partner at Oak Investment Partners from 2003 to 2014. His tenure there provided him with a solid foundation in venture capital and investment strategies. He has been involved in numerous significant transactions, including the merger of iHealth Technologies with Connolly and the acquisition of Therapy Brands by KKR. His professional journey reflects a consistent focus on healthcare investments and successful exits.
Investment Achievements
Andrew Adams has a track record of successful investments and exits in the healthcare sector. He played a pivotal role in the acquisition of Core Informatics by Thermo Fisher Scientific and has been involved with companies such as Sema4, which is publicly traded on NASDAQ under the ticker SMFR. His contributions have significantly impacted the growth trajectories of these companies, showcasing his ability to identify and nurture promising healthcare ventures.